Buying Bitcoin, GDP Shrinks & Earnings recap | ML Daily ft $NUR @MorningstarInc
James West & Ed Milewski deliver the stock market recap and discuss the top news stories for the week ending April 29, 2022.
Transcript
🎙 Midas Letter Daily (00:00)
⁉️ Audience Questions (01:14)
🇺🇸 Elon Musk for President? (01:17)
🐦 Musk Twitter Purchase Effect on Tesla price? (02:22)
🚗 Tesla Inc (NASDAQ:TSLA) chart (02:55)
💰 Bitcoin in 401(k)? (03:03)
🤷♀️ Cathie Wood Fed statements? (04:33)
🔮 What’s next for stock market? (05:13 )
📊 How to invest with inflation? (05:56)
🙉 Jim Cramer stock picks? (08:51)
📡 NuRAN Wireless (CNSX:NUR, OTCMKTS:NRRWF) CEO interview (10:59)
📈 $NUR chart (21:31)
🔋Marbex LLC President Dr David Deak interview (23:51)
⬆️ Inflation (35:40)
⬇️ Recession? (37:45)
🗞 Major indices (39:05)
🪙 Bitcoin $BTC trading strategy (39:25)
📉 Economy & GDP shrinks (42:47)
🏘 US 30 Year Mortgage & real estate (48:50)
⭐️ Morningstar Research EV Equity Strategist interview (53:49)
⚡️ Lithium Americas (NYSE:LAC) chart (1:05:16)
🚙 Lithium Futures (1:05:44)
🏡 Voxtur Analytics (CVE:VXTR) Chart (1:08:59)
Related Articles
Disclosure
Midas Letter is provided as a source of information only, and is in no way to be construed as investment advice. James West, the author and publisher of the Midas Letter, is not authorized to provide investor advice, and provides this information only to readers who are interested in knowing what he is investing in and how he reaches such decisions.
Investing in emerging public companies involves a high degree of risk and investors in such companies could lose all their money. Always consult a duly accredited investment professional in your jurisdiction prior to making any investment decision.
Midas Letter occasionally accepts fees for advertising and sponsorship from public companies featured on this site. James West and/or Midas Letter may also receive compensation from companies affiliated with companies featured on this site. James West and/or Midas Letter also invests in companies on this site and so readers should view all information on this site as biased.
